Publications by authors named "David DeMicco"

Claim this Profile
R
Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD: Real-World Prescribing for Lipid-Lowering Therapy.
Jonathan Arnold, Deeksha Acharya, Hetal Boricha, Himal Chapagain, Aleesha Kainat, David A DeMicco

Am J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.
Michael Szarek, Pierre Amarenco, Alfred Callahan, David DeMicco, Rana Fayyad

J Am Coll Cardiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
David D Waters, Sripal Bangalore, Rana Fayyad, David A DeMicco, Rachel Laskey

J Clin Lipidol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.
Benoit J Arsenault, Francine Petrides, Fatiha Tabet, Weihang Bao, G Kees Hovingh, David DeMicco

J Clin Lipidol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
Liffert Vogt, Sripal Bangalore, Rana Fayyad, Shari Melamed, G Kees Hovingh, David A DeMicco

J Am Heart Assoc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).
Kwok Leung Ong, Nicholas Hui, Andrzej S Januszewski, Nadeem O Kaakoush, Aimin Xu, David A DeMicco

Metabolism· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.
Sripal Bangalore, Rana Fayyad, David A DeMicco, Helen M Colhoun, David D Waters

Circ Cardiovasc Qual Outcomes· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin.
Kwok Leung Ong, David D Waters, Rana Fayyad, Liffert Vogt, Shari Melamed, David A DeMicco

J Am Heart Assoc· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
Gregory G Schwartz, Rana Fayyad, Michael Szarek, David DeMicco, Anders G Olsson

Eur J Prev Cardiol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.
William C Ports, Rana Fayyad, David A DeMicco, Rachel Laskey, Robert Wolk

Clin Drug Investig· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body-Weight Fluctuations and Outcomes in Coronary Disease.
Sripal Bangalore, Rana Fayyad, Rachel Laskey, David A DeMicco, Franz H Messerli

N Engl J Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
Sripal Bangalore, Rana Fayyad, Franz H Messerli, Rachel Laskey, David A DeMicco

Am J Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
Young Sup Byun, Xiaohong Yang, Weihang Bao, David DeMicco, Rachel Laskey

J Am Coll Cardiol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.
Prakash C Deedwania, Terje R Pedersen, David A DeMicco, Andrei Breazna, D John Betteridge

Int J Cardiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
Benoit J Arsenault, Payal Kohli, Gilles Lambert, David A DeMicco, Rachel Laskey

Am J Cardiol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
Sripal Bangalore, Rana Fayyad, John J Kastelein, Rachel Laskey, Pierre Amarenco, David A DeMicco

Am J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.
Benoit J Arsenault, Philip Barter, David A DeMicco, Weihang Bao, Gregory M Preston

PLoS One· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
Sabita S Soedamah-Muthu, Shona J Livingstone, Valentine Charlton-Menys, D John Betteridge, Graham A Hitman, David A DeMicco

Diabetologia· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Gregory G Schwartz, Markus Abt, Weihang Bao, David DeMicco, David Kallend

J Am Coll Cardiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.
Young Sup Byun, Jun-Hee Lee, Benoit J Arsenault, Xiaohong Yang, Weihang Bao, David DeMicco

J Am Coll Cardiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
Sripal Bangalore, Andrei Breazna, David A DeMicco, Chuan-Chuan Wun, Franz H Messerli

J Am Coll Cardiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.
Payal Kohli, David D Waters, Rita Nemr, Benoit J Arsenault, Michael Messig, David A DeMicco

J Am Coll Cardiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, Benoit J Arsenault, Pierre Amarenco, David A DeMicco

J Am Coll Cardiol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Mohammed Iqbal Hawa, Ana Paula Buchan, Thomas Ola, Chuan Chuan Wun, David A DeMicco

Diabetes Care· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
Sripal Bangalore, Rana Fayyad, G Kees Hovingh, Rachel Laskey, Liffert Vogt, David A DeMicco

Am J Cardiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis